Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Commentary
  • Published:

Putting science over supposition in the arena of personalized genomics

Nature Genetics volume 40, pages 939–942 (2008)Cite this article

Colleen McBride and colleagues argue that progress on a multifaceted research agenda is necessary to reap the full benefits and avoid the potential pitfalls of the emerging area of personalized genomics. They also outline one element of this agenda, the Multiplex Initiative, which has been underway since 2006.

Abstract

We explore the process of going from genome discovery to evaluation of medical impact and discuss emerging challenges faced by the scientific community. The need to confront these challenges is heightened in a climate where unregulated genetic tests are being marketed directly to the general public1,2. Specifically, we characterize the delicate balance involved in deciding when genomic discoveries such as gene-disease associations are 'ready' to be evaluated as potential tools to improve health. We recommend that a considerable research commitment be made now in order to successfully bridge the rapidly widening gap between gene-disease association research and the critical (but slower and more involved) investigations into public health and clinical utility. Lastly, we describe a large, ongoing, early-phase research project, the Multiplex Initiative, which is examining issues related to the utility of genetic susceptibility testing for common health conditions.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Baird, P.A. Perspect. Biol. Med. 45, 516–528 (2002).

    Article  PubMed  Google Scholar 

  2. Katsanis, S.H., Javitt, G. & Hudson, K. Science 320, 53–54 (2008).

    Article  CAS  PubMed  Google Scholar 

  3. Haga, S.B., Khoury, M.J. & Burke, W. Nat. Genet. 34, 347–350 (2003).

    Article  CAS  PubMed  Google Scholar 

  4. Hunter, D.J., Khoury, M.J. & Drazen, J.M. N. Engl. J. Med. 358, 105–107 (2008).

    Article  CAS  PubMed  Google Scholar 

  5. Lunshof, J.E., Pirmohamed, M. & Gurwitz, D. Pharmacogenomics 7, 237–241 (2006).

    Article  PubMed  Google Scholar 

  6. Roberts, L. Science 291, 1182–1188 (2001).

    Article  CAS  PubMed  Google Scholar 

  7. Cooke-Deegan, R. Gene Wars: Science, Politics and the Human Genome. (W.W. Norton & Company, New York, 1994).

    Google Scholar 

  8. Khoury, M.J. et al. Genet. Med. 9, 665–674 (2007).

    Article  PubMed  Google Scholar 

  9. Baker, M. Nature 451, 516–517 (2008).

    Article  CAS  PubMed  Google Scholar 

  10. Scheuner, M.T., Sieverding, P. & Shekelle, P.G. J. Am. Med. Assoc. 299, 1320–1334 (2008).

    Article  CAS  Google Scholar 

  11. McClure, J.B. Am. J. Prev. Med. 22, 200–207 (2002).

    Article  PubMed  Google Scholar 

  12. Ory, M.G., Jordan, P.J. & Bazzarre, T. Health Educ. Res. 17, 500–511 (2002).

    Article  CAS  PubMed  Google Scholar 

  13. Zerhouni, E. Science 302, 63–72 (2003).

    Article  CAS  PubMed  Google Scholar 

  14. Hammond, D. et al. Am. J. Prev. Med. 32, 202–209 (2007).

    Article  PubMed  PubMed Central  Google Scholar 

  15. Thrasher, J.F. et al. Addict. Behav. 32, 2916–2925 (2007).

    Article  PubMed  Google Scholar 

  16. Satia, J.A., Galanko, J.A. & Neuhouser, M.L. J. Am. Diet. Assoc. 105, 392–402 (2005).

    Article  PubMed  Google Scholar 

  17. Institute of Medicine. Health Literacy (National Academies Press, Washington, DC, 2004).

  18. Campbell, M. et al. Br. Med. J. 321, 694–696 (2000).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Colleen M. McBride is at the Social and Behavioral Research Branch, National Genome Research Institute, National Institutes of Health, Bethesda, Maryland 20892, USA.,

    Colleen M McBride

  2. Sharon Hensley Alford is at the Henry Ford Hospital, Detroit, Michigan 48202, USA.,

    Sharon Hensley Alford

  3. Robert J. Reid and Eric B. Larson are at the Center for Health Studies, Group Health Cooperative, Seattle, Washington 98101, USA.,

    Robert J Reid & Eric B Larson

  4. Andreas D. Baxevanis and Lawrence C. Brody are at the Genome Technology Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland 20892, USA.,

    Andreas D Baxevanis & Lawrence C Brody

Authors
  1. Colleen M McBride
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sharon Hensley Alford
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Robert J Reid
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Eric B Larson
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Andreas D Baxevanis
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Lawrence C Brody
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Colleen M McBride or Lawrence C Brody.

Rights and permissions

Reprints and permissions

About this article

Cite this article

McBride, C., Alford, S., Reid, R. et al. Putting science over supposition in the arena of personalized genomics. Nat Genet 40, 939–942 (2008). https://doi.org/10.1038/ng0808-939

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/ng0808-939

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing